Skip to content

Evaluation of the Effectiveness of Add-on Hometreatment to Family Based Therapy in Adolescent Anorexia Nervosa.

Evaluation of the Effectiveness of Add-on Hometreatment to Family Based Therapy in Adolescent Anorexia Nervosa. A Randomised Controlled Clinical Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05418075
Acronym
HTED
Enrollment
90
Registered
2022-06-14
Start date
2022-02-01
Completion date
2024-12-31
Last updated
2022-06-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anorexia in Adolescence

Brief summary

The project serves to evaluate a new treatment method with outreach services as a supplement to family-based therapy in the treatment of children and adolescents with eating disorders. The project is intended to help identify different family structures and which families will benefit most from the new outreach service of home-based treatment.

Interventions

OTHERPsychotherapy

If the families agree to participate in the study, they are randomly assigned to a treatment group. In each of the three groups, they are treated with FBT in a weekly session. In the two comparison groups, Hometreatment or MBSR are offered in addition to FBT, with two consultations per week in each case.

Sponsors

Psychiatric University Hospital, Zurich
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
12 Years to 20 Years
Healthy volunteers
No

Inclusion criteria

* Children and adolescents aged 12 -20 years. * Successful registrations in the special consultation for eating disorders at the Clinic for Child and Adolescent Psychiatry and Psychotherapy (KJPP) of the Psychiatric University Hospital (PUK) Zurich. * Diagnosis of anorexia nervosa or atypical anorexia nervosa (ICD-10 F50.00/ F50.01/ F50.1) * Existing informed consent of patients\* (14 years and older) and parents or legal guardians (12-14 years). * IQ over 75 * Resident in the canton of Zurich * Good knowledge of German

Exclusion criteria

* No written consent * Children under 12 years * Other forms of eating disorders apart from anorexia nervosa or atypical anorexia nervosa.

Design outcomes

Primary

MeasureTime frameDescription
Symptomatic improvement3 monthsChange of the reported BMI; Weight in Kg and Height in cm will be combined to report BMI in kg/m\^2

Secondary

MeasureTime frameDescription
State of health improvement3 monthsChange of the Perceived stress scale (PSS) total score measering level of perceived stress and change of the total score in Brief dyadic scale of expressed emotion (BDSEE) measering level of expressed emotion.
Remission rate12 monthsRemission is definde as a Body weight within 15% deviation of the normal weight and clinically unremarkable values in the EDE and EDI

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 10, 2026